New pill shows promise in early breast cancer trial
Disease control
Recruiting now
This early-stage study tests an experimental oral drug called BBI-940 in adults with advanced or metastatic breast cancer. The drug works by breaking down a protein that helps cancer cells grow. It is given alone or with another drug (fulvestrant). The main goals are to check saf…
Phase: PHASE1 • Sponsor: Boundless Bio, Inc. • Aim: Disease control
Last updated May 11, 2026 20:38 UTC